Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Markovitz

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Blood Cells, Molecules & Diseases|August 17, 2014
DEK oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML)Gemma E Logan, Nirit Mor-Vaknin, Till Braunschweig, et al.
Plos Pathogens|May 7, 2025
A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansionMeng Yu, Ang Lin, Faezzah Baharom, et al.
Molecular and Cellular Biology|March 12, 2008
DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stressF Kappes, J Fahrer, M S Khodadoust, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansionMeng Yu, Ang Lin, Faezzah Baharom, et al.
Genes & Development|April 5, 2011
The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrityFerdinand Kappes, Tanja Waldmann, Veena Mathew, et al.
Antiviral Research|April 20, 2011
Synergistic in vitro anti-HIV type 1 activity of tenofovir with carbohydrate-binding agents (CBAs)Geoffrey Férir, Kurt Vermeire, Dana Huskens, et al.
Cancer Research|August 15, 2009
Melanoma proliferation and chemoresistance controlled by the DEK oncogeneMichael S Khodadoust, Monique Verhaegen, Ferdinand Kappes, et al.
Nature Chemical Biology|June 28, 2011
Discovery of selective bioactive small molecules by targeting an RNA dynamic ensembleAndrew C Stelzer, Aaron T Frank, Jeremy D Kratz, et al.
Arthritis and Rheumatism|February 1, 2011
DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigenNirit Mor-Vaknin, Ferdinand Kappes, Amalie E Dick, et al.
The Journal of Infectious Diseases|May 1, 1995
Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakiaD M Walling, N M Clark, D M Markovitz, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Blood Cells, Molecules & Diseases|August 17, 2014
DEK oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML)Gemma E Logan, Nirit Mor-Vaknin, Till Braunschweig, et al.
Plos Pathogens|May 7, 2025
A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansionMeng Yu, Ang Lin, Faezzah Baharom, et al.
Molecular and Cellular Biology|March 12, 2008
DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stressF Kappes, J Fahrer, M S Khodadoust, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansionMeng Yu, Ang Lin, Faezzah Baharom, et al.
Genes & Development|April 5, 2011
The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrityFerdinand Kappes, Tanja Waldmann, Veena Mathew, et al.
Antiviral Research|April 20, 2011
Synergistic in vitro anti-HIV type 1 activity of tenofovir with carbohydrate-binding agents (CBAs)Geoffrey Férir, Kurt Vermeire, Dana Huskens, et al.
Cancer Research|August 15, 2009
Melanoma proliferation and chemoresistance controlled by the DEK oncogeneMichael S Khodadoust, Monique Verhaegen, Ferdinand Kappes, et al.
Nature Chemical Biology|June 28, 2011
Discovery of selective bioactive small molecules by targeting an RNA dynamic ensembleAndrew C Stelzer, Aaron T Frank, Jeremy D Kratz, et al.
Arthritis and Rheumatism|February 1, 2011
DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigenNirit Mor-Vaknin, Ferdinand Kappes, Amalie E Dick, et al.
The Journal of Infectious Diseases|May 1, 1995
Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakiaD M Walling, N M Clark, D M Markovitz, et al.
Pageof 13